Loading clinical trials...
Loading clinical trials...
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adults Aged 18 Years and Older
Conditions
Interventions
Quadrivalent Influenza mRNA Vaccine MRT5410
Quadrivalent Recombinant Influenza vaccine RIV4
+2 more
Locations
25
United States
Joint Clinical Trials Huntington Park Site Number : 8400032
Huntington Park, California, United States
Long Beach Clinical Trials Site Number : 8400056
Long Beach, California, United States
Velocity Clinical Research, North Hollywood Site Number : 8400063
North Hollywood, California, United States
California Research Foundation Site Number : 8400001
San Diego, California, United States
SIMEDHealth, LLC Site Number : 8400042
Gainesville, Florida, United States
Indago Research and Health Center Site Number : 8400002
Hialeah, Florida, United States
Start Date
November 28, 2022
Primary Completion Date
March 28, 2024
Completion Date
March 28, 2024
Last Updated
March 18, 2025
NCT06907511
NCT05426174
NCT04024228
NCT06361875
Lead Sponsor
Sanofi Pasteur, a Sanofi Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions